Retraction Note: Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer

Mohamed A Alfaleh^{1

2}, Omar Fahmy³, Mohammed W Al-Rabia⁴, Mohammed A S Abourehab^{5

6}, Osama A A Ahmed¹, Usama A Fahmy⁷, Helal H Alsulimani¹, Shaimaa M Badr-Eldin^{1

8}, Hibah M Aldawsari^{1

9}, Bander M Aldhabi¹, Awaad S Alharbi¹, Nabil A Alhakamy^{1

9

10}

Affiliations

¹ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
² Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
³ Department of Urology, Universiti Putra Malaysia, 43400, Selangor, Malaysia.
⁴ Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
⁵ Department of Pharmaceutics, and Industrial Pharmacy, Faculty, of Pharmacy, Minia University, Minia, Egypt.
⁶ Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
⁷ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. uahmedkauedu.sa@kau.edu.sa.
⁸ Department of Pharmaceutics and Industrial Pharmacy, Cairo University, Cairo, 11562, Egypt.
⁹ Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
¹⁰ Mohamed Saeed Tamer Chair for Pharmaceutical Industries, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.

Mohamed A Alfaleh et al. Sci Rep. 2024.

. 2024 Nov 13;14(1):27831.

doi: 10.1038/s41598-024-78897-z.

¹ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
² Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
³ Department of Urology, Universiti Putra Malaysia, 43400, Selangor, Malaysia.
⁴ Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
⁵ Department of Pharmaceutics, and Industrial Pharmacy, Faculty, of Pharmacy, Minia University, Minia, Egypt.
⁶ Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
⁷ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. uahmedkauedu.sa@kau.edu.sa.
⁸ Department of Pharmaceutics and Industrial Pharmacy, Cairo University, Cairo, 11562, Egypt.
⁹ Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
¹⁰ Mohamed Saeed Tamer Chair for Pharmaceutical Industries, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.

No abstract available

Retraction of

Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer.
Alfaleh MA, Fahmy O, Al-Rabia MW, Abourehab MAS, Ahmed OAA, Fahmy UA, H Alsulimani H, Badr-Eldin SM, Aldawsari HM, Aldhabi BM, Alharbi AS, Alhakamy NA. Alfaleh MA, et al. Sci Rep. 2022 Nov 14;12(1):19446. doi: 10.1038/s41598-022-24151-3. Sci Rep. 2022. Retraction in: Sci Rep. 2024 Nov 13;14(1):27831. doi: 10.1038/s41598-024-78897-z. PMID: 36376469 Free PMC article. Retracted.